… of new insulin glargine 300 units/mL (Gla-300) with glargine 100 units/mL (Gla-100) in
people with type 2 diabetes using basal insulin (≥42 units/day) plus oral antihyperglycemic …

… Exclusion criteria included use of human mealtime insulin or any premixed or basal insulin
other than insulin glargine or NPH; oral glucose-lowering drugs other than metformin in the …

… For hypoglycemic episodes, U-300 insulin glargine was superior … diabetes using basal
insulin in combination with oral … in a 6-month randomized controlled trial (EDITION 2) …

… clinical efficacy and safety of insulin glargine 300 units/mL (Gla-… A 6-month extension of the
EDITION 1 trial observed that … hypoglycemia and weight gain with new insulin glargine 300 U/…

… control with less hypoglycemia with those new formulations … The non-insulin medications
were continued unchanged provided … with suboptimal glucose control on basal insulin and oral …

… of hypoglycemia, including nocturnal and severe hypoglycemia (… -lowering medication within
3 months; and pump therapy within … insulin: glucose control and hypoglycemia in a 6-month …

… glucose include several classes of oral antihyperglycemic … glycemic control and
reduction in hypoglycemia risk for Gla-… insulin: glucose control and hypoglycemia in a 6-month …

… glargine 300 units/mL (Gla-300), a new long-acting insulin … in the “Hypoglycemia in type 1
and type 2 diabetes” section). … completed the 6-month extension phase of EDITION JP1. HbA …

… New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2
diabetes using oral agents and … in a 6-month randomized controlled trial (EDITION 2)…

… units/mL, published from January 2008 through June 2015. … EDITION 1 was a 6-month
study conducted in adults with … Glycemic control and hypoglycemia with insulin glargine 300 U/…